Combretastatin A-4 phosphate

Combretastatin A-4 phosphate
Combretastatin A-4 phosphate
Systematic (IUPAC) name
Phosphoric acid mono-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenyl} ester
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code  ?
PubChem CID 5351387
Synonyms CA4P
CA4PD
Chemical data
Formula C18H21O8P 
Mol. mass 396.32 g/mol (exact mass : 396.097404)
 YesY(what is this?)  A-4 phosphate (verify)
For more information about this drug and its actions, see combretastatin.

Combretastatin A-4 phosphate (and its disodium salt) is a microtubule destabilizing drug, a type of vascular-targeting agent, a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis. It is a derivative of combretastatin.

Combretastatin A-4 phosphate is a prodrug. In vivo, it is dephosphorylated to its active metabolite, combretastatin A-4.[1]

References